NCT00404651View on ClinicalTrials.gov

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

1,189

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2008

Conditions
DiphtheriaTetanusPertussisHepatitis BPoliomyelitis
Interventions
BIOLOGICAL

DTaP-IPV-HB-PRP~T vaccine

0.5 mL, intramuscular (IM)

BIOLOGICAL

DTaP-IPV-HB-PRP~T vaccine

0.5 mL, IM

BIOLOGICAL

DTaP-IPV-HB-PRP~T vaccine

0.5 mL, IM

BIOLOGICAL

DTaP-HBV-IPV vaccine

0.5 mL, IM

Trial Locations (6)

14050

Tlalpan

56613

Estado de México

Unknown

Estado de México

Insurgentes Cuicuilco

Monterrey

Puebla City

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00404651 - Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants | Biotech Hunter | Biotech Hunter